Skip to main content

OMMA is aware of issues that may affect pending commercial and patient applications submitted prior to June 1, 2023. We are working with our licensing vendor, Thentia, to address this issue. We will be flexible with our applicants while we work towards a resolution. We will update this banner once we have reached a resolution.

Last Modified on May 26, 2023
Back to Top